Obesity Risk

Nearly 70% of Americans may be obese under new norms, study warns

Researchers warn that the findings reflect a growing global health crisis, as outdated BMI standards fail to capture hidden fat-linked risks contributing to chronic disease.

Not just neck pain: How longer screen time is quietly damaging your health

As digital dependency grows, experts warn that prolonged screen time is taking a toll on posture, sleep, and overall health, with many of its effects deeply interconnected

Dr Reddy's to launch obesity drug in 87 nations starting next year: CEO

The company initially plans to launch the generic version in Canada, India, Brazil, Turkey and other emerging markets, subject to patent expiry, Israeli said at a press conference

Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness

India's response to obesity drug Mounjaro 'positive', says Eli Lilly

Mounjaro has sold more than 81,570 units in India, totalling about ₹23.94 crore ($2.76 million) as of May, with the drug logging a 60 per cent rise in overall sales between April and May

HC bars Dr Reddy's, OneSource from selling Wegovy's key element in India

Delhi High Court bars Dr Reddy's and OneSource from selling semaglutide in India, supporting Novo Nordisk's patent rights as it fast-tracks Wegovy launch amid growing obesity drug demand

Obesity cure is here? Why it could be a win-win for all stakeholders

We Indians have had a different perspective around obesity

Eli Lilly to launch its obesity drug at competitive price in India in 2025

Lilly's rival Danish firm Novo Nordisk is also working to bring its obesity drug Wegovy (Semaglutide) to India soon, and according to reports the company may launch Wegovy in 2026

Eli Lilly to boost weight-loss drug supply with $3 billion expansion

The company's s blockbuster weight-loss and diabetes drugs have made it the most valuable pharmaceutical company in the world

Obesity medicines would cost US medicare $35 billion through 2034

Expanding coverage of weight-loss drugs like blockbusters from Eli Lilly & Co. and Novo Nordisk A/S would make 12.5 million more people in the US program eligible

Poor most hit on fertility front due to lifestyle issues: IVF specialist

Infertility is not just a medical condition but a crisis fuelled by lifestyle choices, with infertility rates soaring particularly in lower-income groups and tier 2 and 3 cities where access to healthcare is limited, a top IVF specialist said. Dr Ajay Murdia, the man behind one of India's largest fertility chain, Indira IVF, said while advancements in assisted reproductive technologies like In Vitro Fertilization (IVF) offer hope, it is a reality that the underprivileged who are hit hard. "Infertility rates are soaring, particularly in lower-income and tier 2 and 3 cities, where access to healthcare, nutrition, and education is limited," Dr Murdia, founder and chairman of Indira IVF, told PTI. "Infertility is no longer just a medical issue; it's a crisis fuelled by lifestyle choices that hit the underprivileged hardest. Without action, even advancements like IVF will remain out of reach for many," he said. Lifestyle factors such as obesity, poor diet, smoking, and chronic stress, .

Obesity-linked cancer rates surge in China; young adults most affected

From 2007 to 2021, obesity-related cancer rates in China rose by 3.6% annually, with a striking 15.3% increase for those aged 25 to 29, while rates for non-obesity-linked cancers stayed stable

Novo Nordisk pares 2024 profit outlook amid competition from Eli Lilly

The Danish company lowered its forecast for operating profit growth this year to between 20% and 28% in local currencies, compared to its previous forecast of 22% to 30%

Waist-to-height ratio more effective than BMI for obesity diagnosis: Study

Obesity can no longer be just defined by body mass index (BMI) and rather should be about how body fat is distributed throughout one's body, researchers said while launching a new framework for diagnosing and managing obesity. Published in the journal Nature Medicine, the framework looks specifically at fat accumulated in the abdomen, measured as 'waist-to-height ratio' -- an increased value of which is related to a higher risk of developing cardiometabolic complications, according to the researchers. An "important novelty" of the framework is including a waist-to-height ratio higher than 0.5, along with a BMI of 25-30, for diagnosing obesity, the authors, representing the European Association for the Study of Obesity (EASO), said. "The choice of introducing waist-to-height ratio, instead of waist circumference, in the diagnostic process is due to its superiority as a cardiometabolic disease risk marker," they wrote. Accumulation of abdominal fat is a more reliable predictor of hea

Biocon leads India's push into anti-obesity drugs as patents lapse

The company, helmed by Kiran Mazumdar Shaw, is leading the charge among Indian drugmakers - the world's largest supplier of generic medicines - as they race to grab a slice of the obesity drugs market

Obesity drugs will not solve our billion-person problem, warns WHO

New obesity drugs such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound could be an $80 billion market by 2030

12.5 mn children, teens in India obese in 2022, shows Lancet study

About 12.5 million children aged between five and 19 in India were overweight in 2022, according to a global analysis published in The Lancet journal Of the 12.5, 7.3 million were boys and 5.2 million girls. The total number of children, adolescents and adults worldwide living with obesity has surpassed one billion. These trends, together with the declining prevalence of people who are underweight since 1990, make obesity the most common form of malnutrition in most countries, the researchers said. Obesity and underweight are both forms of malnutrition and are detrimental to people's health in many ways. The latest study provides a highly detailed picture of global trends in both forms of malnutrition over the last 33 years. The analysis by the NCD Risk Factor Collaboration (NCD-RisC) -- a global network of scientists -- and the World Health Organization (WHO) estimates that among the world's children and adolescents, the rate of obesity in 2022 was four times the rate in 1990. It

Covid-19 during pregnancy may increase obesity risk in children: Study

Children born to mothers who contract COVID-19 during pregnancy may be more likely to develop obesity, according to a new study. More than 100 million COVID-19 cases have been reported in the United States since 2019, and there is limited information on the long-term health effects of the infection. Pregnant women make up 9 per cent of reproductive-aged women with COVID-19, which exposes millions of babies to maternal infection during foetal development over the next five years. Our findings suggest that children exposed in utero to maternal COVID-19 have an altered growth pattern in early life that may increase their risk of obesity, diabetes and cardiovascular disease over time, said Lindsay T Fourman, MD, of Massachusetts General Hospital in Boston, Mass. There is still a lot of research needed to understand the effects of COVID-19 on pregnant women and their children, she said. The researchers studied 150 infants born to mothers who had COVID-19 during pregnancy and found the

Nearly one-fourth of all men and women in India are now obese: NFHS

NFHS notes steady increase in obesity among women as household wealth increases

Digital marketing of unhealthy foods, online gaming driving obesity: WHO

The global health body added that while nearly 60 per cent of adults and a third of children are overweight or obese, the last two years of Covid-19 pandemic made that worse